 |
|
Home | Vital Therapies CEO Acquires $20,210 in Stock (VTL) |
 |
Vital Therapies CEO Acquires $20,210 in Stock (VTL)
|
 |
- October 15, 2014
-
Vital Therapies (NYSE:VTL) CEO Terence E. Winters bought 1,360 shares of Vital Therapies stock in a transaction dated Friday, October 10th. The stock was purchased at an average cost of $14.86 per share, with a total value of $20,209.60. Following the transaction, the chief executive officer now directly owns 184,442 shares of the company’s stock, […]This article (Vital Therapies CEO Acquires $20,210 in Stock (VTL)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2014/10/14/vital-therapies-ceo-acquires-20210-in-stock-vtl/
|
 |
|
 |
|
 |
